5 – Other operating income and expenses (XLS:) Download Other operating income (Million €) H1 2019 2018 Income from the adjustment and release of provisions recognized in other operating expenses 22 26 Revenue from miscellaneous activities 86 79 Income from foreign currency and hedging transactions as well as from the measurement of LTI options 26 250 Income from the translation of financial statements in foreign currencies 4 5 Gains on divestitures and the disposal of noncurrent assets 359 40 Income from the reversal of valuation allowances for business-related receivables 12 26 Other 201 772 Other operating income 710 1,198 (XLS:) Download Other operating expenses (Million €) H1 2019 2018 Restructuring and integration measures 423 173 Environmental protection and safety measures, costs of demolition and removal, and project costs not subject to mandatory capitalization 139 167 Amortization, depreciation and impairments of noncurrent assets 272 27 Costs from miscellaneous revenue-generating activities 70 73 Expenses from foreign-currency and hedging transactions as well as from the measurement of LTI options 119 452 Losses from the translation of financial statements in foreign currencies 9 22 Losses from divestitures and the disposal of noncurrent assets 5 10 Expenses from the addition of valuation allowances for business-related receivables 38 33 Expenses for derecognition of obsolete inventory 93 91 Other 352 307 Other operating expenses 1,520 1,355 Income from foreign currency and hedging transactions and from the valuation of LTI options declined from €250 million in the first half of 2018 to €26 million in the first half of 2019. This was mainly the result of lower income from foreign currency transactions and from the release of LTI provisions. The increase in gains on divestitures and the disposal of noncurrent assets in the first half of 2019 was primarily attributable to the merger of the paper and water chemicals business with Solenis and the sale of a development project for seed treatment. In the prior-year period, gains on divestitures related to the sale of the production site for styrene butadiene-based paper dispersions in Pischelsdorf, Austria. Other income decreased to €201 million (H1 2018: €772 million), mainly as a result of lower positive measurement effects from current assets as well as lower insurance refunds. In the first half of 2019, expenses arose from restructuring measures, primarily for the implementation of the new strategy and costs for the integration of the seed and non-selective herbicide businesses acquired from Bayer. The increase in depreciation, amortization and impairments on noncurrent assets was due to the impairment of a natural gas-based investment on the U.S. Gulf Coast, which BASF is no longer pursuing, as well as the optimization of production sites within the Nutrition & Health division in Europe. The decrease in expenses from foreign currency and hedging transactions was primarily attributable to lower measurement effects from current assets. back next